Early surfactant administration protects against lung dysfunction in a mouse model of ARDS.
about
Administration of antenatal glucocorticoids and postnatal surfactant ameliorates respiratory distress syndrome-associated neonatal lethality in Erk3(-/-) mouse pups.The effects of exogenous surfactant administration on ventilation-induced inflammation in mouse models of lung injury.Effects of early administration of a novel anticholinergic drug on acute respiratory distress syndrome induced by sepsis.Role of lung-marginated monocytes in an in vivo mouse model of ventilator-induced lung injury.Apigenin Reduces NF-κB and Subsequent Cytokine Production as Protective Effect in a Rodent Animal Model of Lung Ischemia-Reperfusion Injury.The effect of sRAGE-Fc fusion protein attenuates inflammation and decreases mortality in a murine cecal ligation and puncture model.
P2860
Early surfactant administration protects against lung dysfunction in a mouse model of ARDS.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Early surfactant administratio ...... tion in a mouse model of ARDS.
@en
Early surfactant administratio ...... tion in a mouse model of ARDS.
@nl
type
label
Early surfactant administratio ...... tion in a mouse model of ARDS.
@en
Early surfactant administratio ...... tion in a mouse model of ARDS.
@nl
prefLabel
Early surfactant administratio ...... tion in a mouse model of ARDS.
@en
Early surfactant administratio ...... tion in a mouse model of ARDS.
@nl
P2093
P2860
P1476
Early surfactant administratio ...... ction in a mouse model of ARDS
@en
P2093
James F Lewis
Jaret L Malloy
Vijay P A Rasaiah
P2860
P304
P356
10.1152/AJPLUNG.00391.2002
P577
2003-01-17T00:00:00Z